8 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Cornelia de Lange Syndrome Foundation Research Grants
The CdLS Foundation has a vision and researchers have the determination to find treatments to help individuals with CdLS overcome many of the challenges they face.
Previous Foundation grants have supported research on a range of topics, including dental anesthesia, behavior, aging, parental stress, thrombocytopenia, cell-based studies, and animal models.
$20,000 in funding is available annually. Application's are due by April 15 of each year.
For questions, call 800-753-2357.
American Society of Pediatric Otolaryngology Dustin Micah Harper Recurrent Respiratory Papillomatosis Research Grant
The purpose of this award is to support basic, translational, or clinical research projects in recurrent respiratory papillomatosis (RRP). Clinical or translational research studies are strongly encouraged and should be specifically related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of RRP disease.
Candidates for this award should reside in the U.S. or Canada, be medical students, residents, fellows, private practitioners, Ph.D.s or faculty members. Junior faculty who graduated within 10 years of completing their training will be preferred for this application. Previous ASPO or AAO-HNS Foundation research grant recipients are eligible to compete for this grant. Candidates who have applied for support of the same research from other funding sources, and who are notified of an award from both another agency and from ASPO must choose only one of the awards.
Research supported by this award should be specifically directed toward the pathogenesis, pathophysiology, diagnosis, prevention, or treatment of RRP disease, and may be either basic or clinical/translational in approach. While not specifically required, proposals which aim to introduce new knowledge and methodology from other disciplines to research in RRP disease, or which demonstrate collaborative effort with members of other related disciplines are encouraged. Projects must be designed so as to yield useful information within the period of award, but priority will be given to projects that are also innovative with promise to develop into new long-range or expanded research programs capable of attracting funding from other sources.
The grant application must be accompanied by letters of support from the Chair of the candidate’s academic department or from a principal scientific advisor or mentor (applies to junior faculty, medical students, residents, or fellows). These letters are to indicate a general level of support of the applicant, the fact that the Department will make time, space, and other resources accessible for completion of the project, and that the applicant will have appropriate supervision/support throughout the period of the grant. Applicants must obtain letters of support/understanding from all key personnel on the project. Preference is given to proposed projects that are to be completed within one year, although exceptional proposals that have duration in excess of one year will be considered. No portion of any grant may be used for travel expenses or for principal investigator salaries. If the applicant, department chairman, or at least one investigator is not an ASPO member, a letter of support must also be obtained from an ASPO member. The ASPO member does not need to be affiliated with the applicant’s institution, but must attest to the scientific merit of the application.
1. Amount: $10,000
2. Period: 12 months, non-renewable; maximum of one year no-cost extension allowable with permission of ASPO Research Committee Chair.
3. Use of Funds: A detailed budget and budget justification constitute part of the application and will be evaluated as part of the review process. Funding may not be used to support the Principal Investigator’s salary during the period of the award. Allowable expenses include consultant fees (e.g., statistician); salary support for research assistants or other technical personnel; computer software or hardware; purchase and maintenance of experimental animals; laboratory supplies and services; and expenses related to publication of results directly related to the supported project, exclusive of reprint costs. Equipment and supplies purchased with this Award become the property of the recipient institution. The ASPO prefers not to pay institutional (indirect) costs for this very modest award. If university policy stipulates that a portion of this very modest award must go toward institutional indirect costs, no more than ten percent (10%) of the total costs may be applied for indirect costs. The Total Costs may not exceed $10,000.
4. Review: Applications will be reviewed and scored by members of the Centralized Otolaryngology Research Efforts (CORE) Study Section, composed of ASPO members designated for the Study Section, and members of the AAO-HNSF CORE Study Section Subcommittee. Based on these reviews, the ASPO Research Committee makes recommendations for funding which are presented to the ASPO Board at its COSM meeting. Final funding decisions are made by the ASPO Board.
5. Notification: Letters of notification will be sent by June of the award year. Please do not call the AAO-HNSF office prior to that time to inquire about results. Questions may be directed to the ASPO Research Committee Chair (see ASPO website at www.aspo.us for contact information)
6. Start Date: The recipient of the ASPO Dustin Micah Harper RRP Research Grant will be announced publicly at the closest AAO-HNS Foundation Annual Meeting immediately following the award. Verification of human subjects approval and/or animal use approval, as applicable, as well as verification of tax exempt status must be received prior to release of funds. The awards may be activated as early as July 1 of the year of award, but no later than January 1 of the following year. ASPO reserves the right to revoke an award if relevant approvals have not been obtained within 6 months of notification of a successful application.
Applications are in a similar format to the National Institutes of Health.
All applicants must submit a Letter of Intent online no later than December 16, 2013.
Shwachman-Diamond Syndrome Foundation Grants
Shwachman-Diamond Syndrome (SDS) is a multi-system autosomal-recessive disorder characterized by exocrine pancreatic dysfunction, and varying degrees of marrow dysfunction with cytopenias. Many associated clinical problems have also been described, including skeletal anomalies, metaphyseal dysostosis, rib abnormalities, cleft palate, dental abnormalities and others. Shwachman-Diamond Syndrome Foundation (SDSF) is a nonprofit support organization actively helping the victims of this disease. SDSF is accepting grant requests for research relevant to this disease. Any high quality, innovative research proposal deemed relevant to SDS will be considered. The following are areas of particular interest:
Investigate or evaluate potential novel therapies or potential novel therapeutic strategies- preferred applications
Evaluate predictors of bone marrow abnormalities to determine their correlation with the disease
Determine the causes of and investiagte treatments for bone marrow failure and leukemia
Evaluate protocols and regimens for bone marrow transplants
Evaluate causes and investigate treatments for graft vs host disease and other infections of post bone marrow transplants
Investigations related to adult patient presentation, management, and care including transition from pediatric-centered to adult care
Persons applying for these grants must be in a faculty position with authority to hold an independent research grant (not a training position).
Letter of Intent
The potential applicant should write a one-page letter of intent to the SDSF, indicating the applicant’s position and affiliation, describing their planned project, and explaining its relevance to Shwachman-Diamond Syndrome. These letters are reviewed by SDSF’s Medical and Scientific Advisory Board (MSAB) grant review process.
This letter will be used to identify applicants who will be asked to provide a full application.
The letter is due no later than March 12th. All those who have submitted a letter of intent will receive a reply by April 5th. All Grant Applications must be submitted by May 15th. The final grant decision will be announced by July 31st with a November 1st start date.
Terms of Support
Support may be provided for up to two (2) years in an amount not to exceed $35,000 per year, including expenses. The second year funding will not be released until a Progress Report has been reviewed and approved by the MSAB. The date for the Progress Report is October 1st. Applicants may submit only one grant application at a time, and may hold only one grant at a time.
If you would like us to send you a grant application, have any questions regarding the grant process or have an interest in the disease, please contact SDSF at the address indicated on the home page of our website, call toll free 1-888-825-SDSF (7373) or via email at firstname.lastname@example.org.
Myocarditis Foundation Research Grants
The Myocarditis Foundation is currently accepting applications for Research Grants.
Types of Proposals Sought
The Myocarditis Foundation (MF) accepts fellowship grant applications on an annual basis for innovative basic, clinical or translational research relevant to the cause or treatment of myocarditis. MF’s fellowship grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting preliminary data to help secure long-term funding by the National Institute of Health (NIH) and other major granting institutions. Funding is available at US $35,000 for salary only.
Grant award decisions are made through a peer review process by our Medical Advisory Board. Scientific excellence and relevance to myocarditis are the basic criteria for selecting the supported research project. The award is designed to support training and career development of physician-scientists in myocarditis research.
The MF research grant provides salary support for 1 year of full-time research. The stipend is $35,000. No additional funds for benefits, travel, or indirect costs, etc. are available.
Candidates may apply up to 10 years following receipt of an MD, PhD, or an equivalent degree and plan to perform the funded work in the United States or Canada, in order to apply for the Fellowship. All applicants must select a preceptor with a proven track record of research in myocarditis. In addition to providing a letter of recommendation, the preceptor is expected to assist in preparing the application. For applicants wishing advice in the selection of a preceptor, a list of potential preceptors is available from the MF.
The MF will issue a request for proposals in September of each year. The deadline for grant submission is December 15th with final award decisions made by December 31st. The research plan should be limited to 5 pages and must include the following: hypothesis, specific aims, background/significance, preliminary data, methods and expected results. The applicant should include a cover letter, supporting letter from the preceptor, and applicant and preceptor biographical sketches. Upon receipt of a signed letter of agreement from the selected candidate the MF will disburse the funds in installments during the research year.
A final report will be required upon completion of the research year. The Myocarditis Foundation reserves the right to cite the research in all/any of our printed materials and on our website. The Myocarditis Foundation must be acknowledged in all publications resulting from the research.
The Myocarditis Foundation
100 W Main St Utica, MN 55979
Toll-free US & Canada: 1-866-846-1600
Telephone: (732) 295-3700
Cystinosis Foundation Deanna Lynn Potts Scholarship
Deanna Lynn Potts was born with Cystinosis and lived to be 27 years old. Before she died, she discussed her wishes to start a scholarship fund for children with Cystinosis.
We know how devastating a chronic illness can have on a family emotionally, physically, socially, and financially. Children with Cystinosis are living longer, thanks to medical science and therefore, embarking on careers.
These careers require education. Education is expensive, yet something we do not want to deprive our children of in our world today. Due to the financially draining medical costs, it might prove difficult to send a child to college.
Through this fund, we hope to help some of those students.
PURPOSE: To provide supplemental financial assistance to an undergraduate student diagnosed with Cystinosis enrolled in an accredited collegiate or vocational program.
SCHOLARSHIP AWARD: A $1000 scholarship awarded annually. The award is contingent upon the winners acceptance to an accredited college, university, or vocational program and will be payable to the education institution to be applied to tuition, room and board.
ELIGIBILITY: Each candidate must be a current high school senior, who has Cystinosis and have a financial need.
Documentation/verification of Cystinosis (e.g. letter from physician.)
An official copy of high school transcript.
Two letters of recommendation from current teachers/faculty members and/or counselors regarding applicant's scholastic aptitude and personal qualifications.
An essay of 500 words. We want to know a person who has played a vital role in student's life. How? Why? The essay should be typewritten and double spaced
A copy of the previous year's income tax return.
JUDGING CRITERIA: The essay will earn a possible 40 points and will be judged on the basis of rationale, grammar and comprehension. Transcripts and letters of recommendation will carry a possible additional 20 points. The Cystinosis Foundation Board will establish an independent judging panel to evaluate and rate the applicants. The decision of the judges is final. Finalists may be interviewed before selection is made.
DEADLINE FOR APPLICATION: Application and all accompanying documents must be received at the Cystinosis Foundation Office in a single, flat package by March 30th of each year. You can call the Cystinosis Foundation for an application 888-631-1588.
Remember, the deadline for receiving applications is March 30th of each year.
Call for Research Grant Applications: Cicatricial Alopecia Research Foundation
The Cicatricial Alopecia Research Foundation (CARF) seeks original, focused, and innovative research grant applications dealing with primary cicatricial alopecia (PCA). Applications will be accepted from laboratories around the world. The proposed project must serve to further CARF's research goals, namely, to understand the pathogenesis of PCA, an understanding that will lead to effective prevention and therapy. CARF will give priority to research proposals based on the following topics.
Role of lipids and lipid metabolism in normal hair follicle stem cell biology and cycling
Role of PPARs and other lipid regulators in the pathogenesis of PCA
Role of peroxisomes in hair follicle biology
Role of neuroinflammation in PCA
Role of environmental triggers in the pathogenesis of PCA
Function of sebaceous glands in normal hair follicle biology.
Mechanism of hair shaft egress from the terminal hair follicle
Hair follicle regeneration in a site of tissue repair
GUIDELINES: All applications for grant requests should clearly state research goals, rationale, brief background, and brief experimental protocol. The planned study may not exceed two years in duration. Included in the submission should be a discussion of anticipated results and their potential significance to understanding PCA. Typical awards are $5,000 to $20,000.
A final progress report must be submitted at the end of the funding period. A progress report must be submitted at the end of the first year to obtain a second year no-cost extension. CARF must be acknowledged on all presentations and publications resulting from CARF funded grants.
Applications are reviewed and funded on an annual basis.
Annual application deadline: March 15. Funding decisions made by June 15.
ALS Therapy Alliance Grants Program
Thank you for your interest in submitting a proposal for grant funding to the ALS Therapy Alliance (ATA). Our organization traditionally awards grants from one to three years in term ranging from $100,000 to $1 million in funding to both non- and for-profit companies. National and international companies are eligible to apply.
The following outline will help you prepare the information needed for our next funding review, which happens twice a year in April and November.
Please note grant submission deadlines and number of copies requested in order to ensure timely processing of your application. The ALS Therapy Alliance does not cover indirect costs.
If you have questions about the submission process or this application, please contact Ray Bisson, Grants Manager at (603) 664-5005 or email@example.com, or visit our FAQ page.
What to include with your grant proposal
ATA grant applications should follow the following format and adhere strictly to the maximum page limits (using only 11 point font or greater):
■ Abstract (1 page)
■ Background and Significance (2 pages)
■ Preliminary Data (2 pages)
■ Experimental Plan (3 pages)
■ References (no limit)
■ Budget Justification
■ NIH Biosketch (including present and pending support, 4 pages maximum) for PI's, post-docs and others involved in the project (excluding laboratory technicians)
■ Letters of collaboration and support
Grant proposal submission deadlines
To have your grant proposal reviewed at our April meeting, please submit by March 15th. To have your grant proposal reviewed at our November meeting, please submit by October 15th.
Where to send your grant proposal
Please email your proposal in PDF format to firstname.lastname@example.org.
Sjögren’s Syndrome Foundation Research Grants Program
The Sjögren’s Syndrome Foundation strives to foster research that will have the greatest potential impact on Sjögren’s patients, ensuring new therapeutics are developed and a cure found.
One important way in which we strive for change is to promote innovative research that will have the greatest impact on the lives of those who have this prevalent and devastating disease. We want to help spur the research community to generate fresh ideas that will bring novel approaches to treatment and the development of new therapeutics and lead to a cure. The SSF currently focuses on many initiatives to reach this goal, including: the development of Clinical Practice Guidelines, the launching of a Clinical Trials Consortium, advocacy among federal research entities, and through the SSF Research Grants Program.
The SSF Research Grants Program places a high priority on both clinical and basic scientific research into the cause, prevention, detection, treatment, and cure of Sjögren’s, with support provided to investigators at every career level from student to junior investigator to senior-level leader.
SSF Research Funding Priorities
Innovation is key for all SSF research funding. We must inspire new ideas and the gathering of data necessary to determine if those ideas are viable so that investigators can take a risk to pursue a concept that could prove to be a major breakthrough in Sjögren’s.
Funding decisions for SSF grants will be based on the following priorities:
• Innovative and creative concepts
• Novel diagnostics and relevance to the SSF Breakthrough Goal
• Direct relevance to Sjögren’s
• High quality science
• Preliminary data; probability of SSF seed money leading to an NIH grant
• Potential practical importance through the use of human tissues or blood samples
• Outcome could define new therapeutic target in SS
• Collaborative aspects of project
• Focused and achievable in the time lines
• Author on peer-reviewed articles
• A young investigator who has already displayed a productive commitment to SS research and a potential career in the field
• Letters of recommendation (if required) praise commitment, focus, high standards and excellence Financial support important for the salary support and execution of the research
•Excellent lab environment and mentorship available if young investigator
Grants will be awarded in amounts ranging between $15,000 and $50,000 a year for two years, depending on satisfactory progress. A human study that reviewers deem to be the most innovative project will be eligible for a $50,000 grant. All investigators will submit a budget for$35,000 and revise the budget once an award offer is accepted.
SSF research grants are open to basic and clinical scientists holding an advanced degree (MD, DDS, DMD, or PhD) at any U.S. university or research institution. Both junior and senior investigators may apply. For physicians, advanced clinical training in a specialty related to Sjögren’s, such as rheumatology or ophthalmology, is desirable.
The application receipt deadline is February 1, 2015. The grant funding period is July 1 through June 30.
Sjögren's Syndrome Foundation
6707 Democracy Boulevard
Bethesda, MD 20817
Toll Free: (800) 475-6473
Local call: (301) 530-4420
Fax: (301) 530-4415